On Saturday the Food and Drug Administration approved the use of two antimalarial drugs, hydroxychloroquine and a related medication, chloroquine, for emergency use to treat COVID-19. The drugs were touted by President Trump as a “game changer” for COVID-19.

However, a study just published in a French medical journal provides new evidence that hydroxychloroquine does not appear to help the immune system clear the coronavirus from the body. The study comes on the heels of two others – one in France and one in China – that reported some benefits in the combination of hydroxychloroquine and azithromycin for COVID-19 patients who didn’t have severe symptoms of the virus.


I am a medicinal chemist who has specialized in discovery and development of antiviral drugs for the past 30 years, and I have been actively working on coronaviruses for the past seven. I am among a number of researchers who are concerned that this drug has been given too much of a high priority before there is enough evidence to show it is indeed effective.

There are already other clinical studies that showed it is not effective against COVID-19 as well as several other viruses. And, more importantly, it can have dangerous side effects, as well as giving people false hope. The latter has led to widespread shortages of hydroxychloroquine for patients who need it to treat malaria, lupus and rheumatoid arthritis, the indications for which it was originally approved.

The idea that the combination of hydroxychloroquine with an antibiotic drug, azithromycin, was effective against COVID-19 gained more attention after a study published on March 17. This study described a trial of 80 patients carried out by Philippe Gautret in Marseille, France. Although some of their results appeared to be encouraging, it should also be noted that most of their patients only had mild symptoms. Furthermore, 85% of the patients didn’t even have a fever – one of the major telltale symptoms of the virus, thus suggesting that these patients likely would have naturally cleared the virus without any intervention.

In another study, posted on medRxiv, which has not yet been peer-reviewed, Chinese scientists from Renmin Hospital of Wuhan University, in Wuhan, China, gave hydroxychloroquine to patients with only mild infections who were free of medical issues, similar to the Gautret study. The results showed that the 31 patients who received the drug showed a lessening of their symptoms 24 hours earlier than patients in the control group. In addition, pneumonia symptoms improved in 25 of the 31 patients versus 17 of 31 in the control group. As noted in several of the comments associated with the manuscript, there are issues related to the translation of the paper, thus clouding interpretations of some of the results. The paper also appears to focus more on pneumonia than COVID-19. However, these issues may be cleared up or addressed once the paper finishes the peer-review process.

But two other studies have conflicting results.

A second French group, led by Jean-Michel Molina, has now tested the hydroxychloroquine-azithromycin combination treatment in 11 patients at the Hôpital Saint-Louis in Paris, France, and their results were strikingly different.

Like the Marseille study, the Molina trial was also a small pilot study. Molina and colleagues used the same dosing regimen as Gautret. In contrast, however, to the Gautret study, eight of the 11 patients had underlying health conditions, and 10 of 11 had fevers and were quite ill at the time the dosing began.

These Paris researchers found that after five to six days of treatment with hydroxychloroquine (600 mg per day for 10 days) and azithromycin (500 mg on day 1 and 250 mg on days 2 to 5), eight of the 10 patients still tested positive for COVID-19. Of these 10 patients, one patient died, two were transferred to the ICU and another had to be removed from the treatment due to serious complications.

In addition, a similar study in China also showed no difference in viral clearance after seven days either with or without the hydroxychloroquine with the patients in the trial. This supports Molina’s findings.

Thus, despite the recent approval of this drug for use against COVID-19, questions remain as to the efficacy of this treatment. As Molina and colleagues note: “Ongoing randomized clinical trials with hydroxychloroquine should provide a definitive answer regarding the alleged efficacy of this combination and will assess its safety.”

Katherine Seley-Radtke is Professor of Chemistry and Biochemistry and President-Elect of the International Society for Antiviral Research, University of Maryland, Baltimore County

This article originally appeared on The Conversation. You can read it here.

  • A dementia patient and his wife got their lives back thanks to a ‘coat rack-like’ robot
    Photo credit: Canva/Hello RobotStretch 4 could be one of many options for advanced senior care.

    Brenda and Brian Marquis are part of a growing senior population with mental and physical ailments. In particular, Brian has dementia from a brain injury he sustained in 2012. Brenda would help Brian remember to wash himself, eat lunch, and other tasks. On top of that, both live with other physical, cognitive, and emotional disabilities that make day-to-day living difficult. Then came “Robbie.”

    “Robbie” is the robot that helps the Marquis family with their daily routines at home. Resembling a coat rack, the robot was presented to the Marquis family after Brenda sent an email to the University of New Hampshire inquiring about robotic service dogs. Booker T. Bones, the family’s service dog, had passed away and Brenda was looking for similar support. The university saw this as an opportunity for its computer science center to experiment with “socially assistive” robots.

    “Our goal is not to replace a human caregiver but to use technology such as robots to provide complementary care,” Sajay Arthanat, a professor in UNH’s Department of Occupational Therapy told WMUR. “We know that caregivers often have to perform a lot of repetitive, mundane tasks.”

    What exactly is “Robbie”?

    “Robbie” is a Stretch 4 robot model invented by Hello Robot. While a very simple in design, the robot is able to help Brian with a number of tasks. It reminds him to eat meals at specific times, fetches items such as water bottles out of the fridge, reads the fine print of prescription medications, and more. Stretch 4 also has prompts that activate when he enters certain rooms of the home, such as the bathroom.

    “I was never into technology,” Brian Marquis said to Sentinel Colorado. “Then I realized I can’t remember to wash my face and my armpits. So, it just really kind of set me free almost.”

    Robbie hasn’t just helped Brian live more independently, but Brenda as well. She doesn’t have to be by Brian’s side 24/7. Now, she can go out and play mahjong with her friends without worrying about leaving Brian alone for several hours.

    A growing issue for older Americans

    Per the Department of Health and Human Services, the majority of older adults are projected to need long-term care and service. This could range from basic needs to extreme health cases. In addition, a 2025 report released by the Bureau of Labor Statistics found that 38.2 million people provided unpaid elder care. Around 28% of those people provided nearly four hours of unpaid elder care per day.

    The number of people who need such help is projected to grow exponentially. By 2030, the number of Americans over 65 is expected to surpass the number under 18 for the first time in U.S. history. The number of Americans over 65 years old is projected to reach 82 million, a 40% growth from 2022.

    This is, in part, why there has been such massive investment in robots and A.I. specializing in caring for elderly people. It’s not just to ensure that the elderly have the assistance they need for day-to-day tasks. Eldercare robots also boost their patient’s confidence by allowing them to live as safely and independently as they can. In addition to task-oriented robots like Stretch 4, there are also robots to assist with mobility.

    Robotics are helping improve the lives of the elderly as a new and exciting care option. With the help of medication, personal care from a human, community, and more, the growing elderly population can thrive through their golden years. For more eldercare resources, visit the National Institute on Aging.

    Whether through use of a robot or not, finding solutions to aid and care for our older populations ultimately benefits society as a whole.

  • Who are hospital ethics consultants, and why should you care?
    Photo credit: LPETTET/E+/Getty Images End-of-life decisions can be complicated, and ethics consultants may help families and care teams navigate them.
    ,

    Who are hospital ethics consultants, and why should you care?

    Helping families face the hardest medical choices.

    Imagine the following scenarios:

    A surgeon prepares to amputate a patient’s foot to save his life, but the patient refuses the procedure. His decline in thinking and memory raises doubts about his ability to consent, and he has no family or friends to help with the decision.

    A 17-year-old declines a liver transplant, while her mother insists on going forward with the lifesaving surgery.

    Siblings stand divided at the bedside of their 85-year-old mother with dementia, one rejecting a feeding tube, the other calling it a basic human necessity.

    I am a hospital ethics consultant, and these are the kinds of situations my colleagues and I regularly encounter. Yet many people are unaware that hospital ethics consultants even exist – or that they can ask for one.

    Who are hospital ethics consultants?

    Healthcare ethics consultants are trained to help patients, families and clinicians navigate difficult medical decisions.

    They could be called in situations where healthcare staff struggles with providing procedures such as cardiac resuscitation that are unlikely to benefit the patient and might even cause more pain and suffering. They could also be called when it is unclear who has authority to consent for a patient’s care, or when end-of-life decisions are complicated and resources are limited – such as ICU beds and ventilators during COVID-19.

    Ethics consultants come from a range of disciplines: physicians, nurses, social workers, chaplains, lawyers and philosophers who have specialized training and experience in clinical ethics. Since 2018, ethics consultants are increasingly pursuing formal certification through the American Society for Bioethics and Humanities.

    What is their origin?

    The modern field of bioethics emerged from the 1947 Nuremberg Doctors’ Trial, where Nazi physicians were prosecuted for conducting brutal medical experiments on imprisoned people.

    This led to the 1947 framework outlining ethically acceptable human research called the Nuremberg Code, written by a panel of American judges. The 1979 Ethical Principles and Guidelines for Protections of Human Subjects of Research, called the Belmont Report, followed the Nuremberg Code. The Belmont Report turned the ethical ideals of respect for persons, beneficence – to do good – and justice into a regulatory framework to protect vulnerable and marginalized medical research participants in the U.S.

    In the 1980s, many of these ethics protections moved from the research lab to the patient bedside. During this time, lifesaving technologies such as the ventilator, dialysis machine and organ transplantation created new, difficult ethical questions: When should life support end? Who decides? And what happens when there aren’t enough resources?

    A series of court cases and laws expanded patients’ rights, with the Patient Self-Determination Act, a 1990 law which upheld patient rights to refuse or accept medical treatment, marking the key turning point.

    A ventilator connected to a patient shows vital readings on a blue screen in a hospital room.
    Lifesaving technologies have revolutionized medicine, but they also raise ethical questions about who receives care when resources are scarce. Jackyenjoyphotography/Moment via Getty Images

    High-profile court cases exposed the ethical dilemmas around end-of-life care and patient self-determination. The 1976 case, In re Quinlan, involved Karen Ann Quinlan, a young woman in a persistent vegetative state whose family sought permission from the court to withdraw her ventilator.

    Following In re Quinlan was the 1990 case, Cruzan v. Director, Missouri Department of Health, which affirmed that adults have the right to refuse life-sustaining treatment.

    Both cases became touchstones for how ethics consultants and care teams navigate the life‑and‑death decisions that have become routine in an era of life‑sustaining technology.

    Today, most hospitals have some formal process for addressing ethical concerns in patient care.

    What do ethics consultants actually do?

    A member of the healthcare team usually requests an ethics consult when they face conflict or uncertainty about the care of a patient. Patients and families can also request an ethics consultation, but in reality, few know this option exists or feel empowered to use it.

    The ethics consultant’s first task is to gather as much information as possible from everyone involved to understand the full context of the case. Importantly, ethics consultants do not make treatment decisions; they assist the people who do.

    Imagine a loved one with advanced dementia who is in the intensive care unit with respiratory failure and is on a ventilator. The physician believes further treatment will prolong suffering; the family is not willing to let him go.

    An ethics consultant would be called by the family or healthcare team to slow things down, provide space to reflect, and help navigate the situation. The ethics consultant will often meet with everyone involved to ensure that all voices are heard and that the patient’s wishes remain central to the discussion.

    As part of the ethics review, the ethics consultant would draw on their knowledge of policies, laws and ethical precedent about withdrawing life-sustaining treatment to provide some guardrails for the situation. In this case, a legal guardrail might be that the physician cannot remove the ventilator without the family’s consent.

    Rather than making a decision, the ethics consultant would then outline the ethical options available from which the patient, family, and healthcare team can choose.

    Why are ethics consultants a valuable resource?

    Ethics consultants are trained to help people work through not just the medical facts, but the deeply human questions beneath them: What counts as an acceptable quality of life? How do we weigh hope against suffering? How can we know what a patient would want if they cannot speak for themselves?

    In these moments, decisions can feel urgent and heavy, and communication can easily break down. Ethics consultants don’t take decisions away from patients or families, and they don’t replace the role of clinicians. Instead, they help ensure that everyone understands the situation, that different perspectives are heard and that the conversation stays grounded in the values and goals of the patient.

    They also bring something that families often don’t realize they need until tensions rise: a calm, measured presence. By clarifying misunderstandings, naming sources of conflict and guiding difficult conversations, they help families and care teams find a way forward together.

    The choices may still be painful – and there may be no perfect answer – but with the right support, those decisions can feel more thoughtful, more shared and more aligned with what matters most.

    This article originally appeared on The Conversation. You can read it here.

  • Gen Z and Millennials are ditching dating and finding fulfillment through ‘solo-maxxing’ trend
    Photo credit: CanvaYounger adults are choosing to spend more time on themselves than on dates.

    As the economy is in flux, the price of everything is increasing, including dating. According to some reports, an average night out has risen to nearly $200. For this reason and others, a new trend is forming for Millennials and Gen Z that’s been dubbed “solo-maxxing.” While these solo-maxxers are doing activities without a partner, they’re not lonely. In fact, they’re thriving.

    Solo-maxxing is one of several “maxxing trends” that have become popular points of discussion on social media. In short, “maxxing” is slang for maximizing and optimizing a specific part of life to its fullest potential. For example, “looksmaxxing” is trying to enhance a person’s physical appearance through beauty routines, exercise, and the like. A person who takes melatonin, puts on a white noise machine, has full blackout curtains in their bedroom, etc. could be “sleepmaxxing.”

    What makes a person a solo-maxxer?

    In this case, solo-maxxing is a similar maxxing self-care trend that has people reframing singlehood. While the higher price tags for dates and dating apps are a motivator, these solo-maxxers’ main motivation is to achieve contentment through independence without a partner. It’s making living the single life one that is desirable and by choice. Whether it’s burnout from dating or the expense, a survey of 14,380 adults aged 18 to 34 found that life was “more peaceful” when not in a relationship.

    The appeal of solo-maxxing is multi-faceted. There is a sense of stability and independence in that you’re on your own. While a person still has to worry about their own finances, goals, happiness, etc., there is no pressure or distraction to shift focus onto another person’s situation as well. Eyes on their own paper. Many of these solo-maxxers are using their non-dating time to learn a new skill, try a new hobby, and/or pursue a passion. They are dedicating their time and resources to make themselves a complete person without needing another half.

    Solo-maxxing vs. loneliness

    While this is all well and good, it can be easy to just adopt the term solo-maxxing to hide a loneliness issue. The high cost of dating also contributes to the high loneliness epidemic among Gen Z. Other reasons for this loneliness include less physical third-spaces, overall expenses, and social media. 

    This loneliness shouldn’t be confused with solo-maxxing. After all, maximizing yourself as an unattached person doesn’t mean you’re physically by yourself, you’re just self-focused. Solo-maxxing can look like going to cooking classes so you don’t have to rely on anyone for delicious meals. It can mean signing up at a dojo to learn a martial art. If what you are doing is helping build confidence and isn’t just avoiding people, it is likely a positive solo-maxxing activity.

    It is important to fully analyze and be honest with yourself when participating in this trend. If you’re masking loneliness and depression with a solo-maxxing label, you may want to reconsider and seek help. However, solo-maxxing is an option if you are burnt out by the dating scene, don’t want to waste money on potential dates that go nowhere, and have goals that a relationship might hinder. 

    Who knows? Maybe during a solo-maxxing activity you meet a fellow solo-maxxer and later decide to become duo-maxxers. Even if not, you can still feel confident and complete in life just on your own.

Explore More Health Stories

Health

Who are hospital ethics consultants, and why should you care?

Well-being

Gen Z and Millennials are ditching dating and finding fulfillment through ‘solo-maxxing’ trend

Well-being

Scientists discover how long it takes for the brain to alter and change during meditation

Health

Is rubbing your eyes bad for you? 2 eye specialists explain what’s behind the urge to rub and what to do about it